PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.31
+2.46 (3.47%)
At close: Aug 7, 2026, 4:00 PM EDT
72.00
-1.31 (-1.79%)
After-hours: Aug 7, 2026, 7:34 PM EDT

PTC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,050984.65779.71594279.83189.72
Short-Term Investments
1,179960.72359.99282.74130.87583.66
Cash & Short-Term Investments
2,2291,9451,140876.74410.71773.38
Cash Growth
12.06%70.69%29.99%113.47%-46.89%-29.93%
Accounts Receivable
239.04181.62158.55160.82155.61110.46
Inventory
91.3579.6523.1930.5821.8115.86
Other Current Assets
57.8867.3144.09150.49105.6654.68
Total Current Assets
2,6172,2741,3661,219693.79954.37
Net Property, Plant & Equipment
126.27135.42117.66178.99175.02130.01
Other Intangible Assets
402.93388.75118.79379.5705.89724.84
Goodwill
82.3482.3482.3482.3482.3482.34
Other Long-Term Assets
21.5818.320.736.2548.5846.5
Total Assets
3,2502,8991,7051,8961,7061,938

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
382.25381.27304.29391.98320.37288.78
Current Portion of Long-Term Debt
55.45286.63---149.54
Current Portion of Leases
17.9715.4813.361612.3710.27
Unearned Revenue
1.192.045.510.81.35-
Other Current Liabilities
314.22283257.82194.3172.1560.75
Total Current Liabilities
771.07968.43580.98603.1406.24509.35
Long-Term Debt
535.52-285.41284.21571.72281.89
Long-Term Leases
87.5396.5890.52114.81119.5493.67
Other Long-Term Liabilities
2,0222,0391,8461,712955.211,052
Total Long-Term Liabilities
2,6452,1362,2222,1111,6461,427
Total Liabilities
3,4163,1042,8032,7142,0531,937

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.080.080.070
Additional Paid-in Capital
2,7122,7482,5752,4662,3052,124
Accumulated Other Comprehensive Income
6.0210.5-25.89-1.294.8-24.28
Retained Earnings
-2,884-2,964-3,647-3,284-2,657-2,098
Shareholders' Equity
-165.36-205.31-1,098-818.56-347.091.37
Total Liabilities & Equity
3,2502,8991,7051,8961,7061,938

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
696.47398.7389.3415.03703.63535.38
Net Cash (Debt)
1,5331,547750.4461.71-292.92238
Net Cash Growth
-4.27%106.11%62.52%---65.16%
Net Cash Per Share
17.9117.519.776.17-4.083.38
Book Value
-165.36-205.31-1,098-818.56-347.091.37
Book Value Per Share
-1.93-2.32-14.29-10.94-4.840.02
Tangible Book Value
-650.63-676.41-1,299-1,280-1,135-805.81
Tangible Book Value Per Share
-7.60-7.66-16.91-17.11-15.83-11.44
SEC Filings: 10-K · 10-Q